CIK 0000883975 · Non-accelerated filer<br>Smaller reporting company
Microbot Medical Inc.
Sign in to watch- Ticker
- MBOT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943078125
- Phone
- 908-938-5561
- Business address
- 25 RECREATION PARK DR SUITE 108, HINGHAM, MA, 02043
- Former names
- Microbot Medical Inc., STEMCELLS INC, CYTOTHERAPEUTICS INC/DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-01 | Burell Scott R Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2026-04-01 | Laxminarain Prattipati Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2026-04-01 | Stockburger Aileen Ptucha Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2026-04-01 | Madden Martin J. Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2026-04-01 | Wenderow Tal Baruch Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2026-04-01 | Wilson David James Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2026-02-18 | Diaz-Cartelle Juan Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +105,000 | 105,000 | ||
| 2026-02-18 | Gadot Harel Chairman, President and CEO | Grant or award · Stock Option (Right to Buy) | +480,000 | 480,000 | ||
| 2026-02-18 | Vaknin Rachel Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +105,000 | 105,000 | ||
| 2026-02-18 | Sharon Simon General Manager, CTO | Grant or award · Stock Option (Right to Buy) | +105,000 | 105,000 | ||
| 2025-02-05 | Vaknin Rachel Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +48,125 | 48,125 | ||
| 2025-02-05 | Sharon Simon General Manager, CTO | Grant or award · Stock Option (Right to Buy) | +43,750 | 43,750 | ||
| 2025-02-05 | Gadot Harel Chairman, President and CEO | Grant or award · Stock Option (Right to Buy) | +228,000 | 228,000 | ||
| 2025-02-05 | Diaz-Cartelle Juan Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +42,000 | 42,000 | ||
| 2025-01-28 | Stockburger Aileen Ptucha Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2025-01-28 | Madden Martin J. Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2025-01-28 | Burell Scott R Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2025-01-28 | Wenderow Tal Baruch Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2025-01-28 | Wilson David James Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2025-01-28 | Laxminarain Prattipati Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 |
Page 1 of 6 · 114 trades